The Barchart has this ticker' 2nd resistance point at a 1.586.....i know with any substantial news release this will fly beyond that in a few minutes, if not b4 that...RJS mentioned that we are due for some news about the keytruda/ae37 study that is being undertaken by the NSABP, or the much awaited 10Q 2nd quarter generex with veneto's revenue included....those 2 news catalysts will shoot this ticker beyond icaredoyou's agenda...

2nd Resistance Point 1.5860
1st Resistance Point 1.5580
Last Price 1.5300
1st Support Level 1.5010
2nd Support Level 1.4720


Did not mention Merck in my post.....for fun....but can't resist:

https://www.streetinsider.com/FDA/Generex+Bio...15919.html